Simple and Sensitive Spectrophotometric Determination of
... Two simple, sensitive and extraction-free spectrophotometric methods have been developed for the determination of olanzapine (OLP) both in pure form and in pharmaceutical formulations. The methods are based on the formation of yellow coloured ion-pair complexes between OLP and two sulphonphthalein a ...
... Two simple, sensitive and extraction-free spectrophotometric methods have been developed for the determination of olanzapine (OLP) both in pure form and in pharmaceutical formulations. The methods are based on the formation of yellow coloured ion-pair complexes between OLP and two sulphonphthalein a ...
Simultaneous Quantitative Determination of Candesartan cilexetil
... methods was tested over a long period of t ime. One port ion of a standard solution was kept at room temperature and another portion was stored under refrigeration at approximately 48ºC, and the content of these solutions was regularly co mpared with that of a freshly prepared solution. Accuracy (% ...
... methods was tested over a long period of t ime. One port ion of a standard solution was kept at room temperature and another portion was stored under refrigeration at approximately 48ºC, and the content of these solutions was regularly co mpared with that of a freshly prepared solution. Accuracy (% ...
zantac 150 zantac 300 zantac 25 zantac
... excretion of procainamide and N-acetylprocainamide resulting in increased plasma levels of these drugs. Although this interaction is unlikely to be clinically relevant at usual ranitidine doses, it may be prudent to monitor for procainamide toxicity when administered with oral ranitidine at a dose e ...
... excretion of procainamide and N-acetylprocainamide resulting in increased plasma levels of these drugs. Although this interaction is unlikely to be clinically relevant at usual ranitidine doses, it may be prudent to monitor for procainamide toxicity when administered with oral ranitidine at a dose e ...
micronor - Janssen
... performed, including a blood pressure determination. Breasts, liver, extremities, and pelvic organs should be examined. A Papanicolaou (Pap) smear should be taken if the patient has been sexually active. The first follow-up visit should be done 3 months after oral contraceptives are prescribed. Ther ...
... performed, including a blood pressure determination. Breasts, liver, extremities, and pelvic organs should be examined. A Papanicolaou (Pap) smear should be taken if the patient has been sexually active. The first follow-up visit should be done 3 months after oral contraceptives are prescribed. Ther ...
Name of Medicine
... Dosage is best initiated with one tablet of SINEMET 25/100 three times a day. This dosage schedule provided 75 mg of carbidopa per day. Dosage may be increased by one tablet every day or every other day (given at intervals of 3-4 hours), as necessary, until a dosage equivalent of eight tablets of SI ...
... Dosage is best initiated with one tablet of SINEMET 25/100 three times a day. This dosage schedule provided 75 mg of carbidopa per day. Dosage may be increased by one tablet every day or every other day (given at intervals of 3-4 hours), as necessary, until a dosage equivalent of eight tablets of SI ...
SERC PM
... Pediatrics (< 18 years of age) The safety and efficacy of SERC® in pediatric patients below 18 years of age have not been evaluated, therefore its use in this population is not recommended. Geriatrics (> 65 years of age) Limited data from clinical studies suggest that a dosage adjustment is unlikel ...
... Pediatrics (< 18 years of age) The safety and efficacy of SERC® in pediatric patients below 18 years of age have not been evaluated, therefore its use in this population is not recommended. Geriatrics (> 65 years of age) Limited data from clinical studies suggest that a dosage adjustment is unlikel ...
product monograph serc
... Pediatrics (< 18 years of age) The safety and efficacy of SERC® in pediatric patients below 18 years of age have not been evaluated, therefore its use in this population is not recommended. Geriatrics (> 65 years of age) Limited data from clinical studies suggest that a dosage adjustment is unlikel ...
... Pediatrics (< 18 years of age) The safety and efficacy of SERC® in pediatric patients below 18 years of age have not been evaluated, therefore its use in this population is not recommended. Geriatrics (> 65 years of age) Limited data from clinical studies suggest that a dosage adjustment is unlikel ...
formulation development and stability studies of vitamin D3
... to aqueous solution employed. Decreased content uniformity increased running cost as decreased productive are the other disadvantages. Recently soft capsules containing a vegetable oil solution of active vitamins D3 have also developed. However, soft capsules have their particular drawbacks such as ...
... to aqueous solution employed. Decreased content uniformity increased running cost as decreased productive are the other disadvantages. Recently soft capsules containing a vegetable oil solution of active vitamins D3 have also developed. However, soft capsules have their particular drawbacks such as ...
ADHD drugs compared - Consumer Health Choices
... disorder (ADHD) is part of a Consumer Reports project to help you find safe, effective medicines that give you the most value for your healthcare dollar. To learn more about the project and other drugs we’ve evaluated, go to www.CRBestBuyDrugs.org. We focus in this report on the use of ADHD drugs to ...
... disorder (ADHD) is part of a Consumer Reports project to help you find safe, effective medicines that give you the most value for your healthcare dollar. To learn more about the project and other drugs we’ve evaluated, go to www.CRBestBuyDrugs.org. We focus in this report on the use of ADHD drugs to ...
Product Monograph Template - Standard
... The duration of the treatment should be kept as short as possible and should not be continued after the symptoms have disappeared. It is advisable to limit treatment to about 14 days, as during chronic administration the activity of pseudoephedrine diminishes with time. Recommended Dose and Dosage A ...
... The duration of the treatment should be kept as short as possible and should not be continued after the symptoms have disappeared. It is advisable to limit treatment to about 14 days, as during chronic administration the activity of pseudoephedrine diminishes with time. Recommended Dose and Dosage A ...
Product Monograph
... NSAIDs, caution should be used in the treatment of elderly patients who are more likely to be suffering from impaired renal, hepatic or cardiac function. For high-risk patients, alternate therapies that do not involve NSAIDs should be considered. NAPROSYN is NOT recommended for use with other NSAIDs ...
... NSAIDs, caution should be used in the treatment of elderly patients who are more likely to be suffering from impaired renal, hepatic or cardiac function. For high-risk patients, alternate therapies that do not involve NSAIDs should be considered. NAPROSYN is NOT recommended for use with other NSAIDs ...
Sinemet® CR Product Monograph
... that these events are NOT limited to initiation of therapy. Patients should also be advised that sudden onset of sleep has occurred without warning signs and should be specifically asked about factors that may increase the risk with SINEMET® CR such as concomitant medications or the presence of slee ...
... that these events are NOT limited to initiation of therapy. Patients should also be advised that sudden onset of sleep has occurred without warning signs and should be specifically asked about factors that may increase the risk with SINEMET® CR such as concomitant medications or the presence of slee ...
DP-Anastrozole
... DP-ANASTROZOLE 1 mg is unlikely to impair the ability of patients to drive or operate machinery. However, asthenia and somnolence have been reported and caution should be taken while such symptoms persist. ...
... DP-ANASTROZOLE 1 mg is unlikely to impair the ability of patients to drive or operate machinery. However, asthenia and somnolence have been reported and caution should be taken while such symptoms persist. ...
How to use the BNF - NHS Education for Scotland
... details of these labels could be found in Appendix 3. As these labels have now been applied at the level of the dose form, a full list of medicinal products with their relevant labels would be extensive. This list has therefore been removed, but the information is retained within the monograph. In t ...
... details of these labels could be found in Appendix 3. As these labels have now been applied at the level of the dose form, a full list of medicinal products with their relevant labels would be extensive. This list has therefore been removed, but the information is retained within the monograph. In t ...
Two-Piece Hard Capsules for Pharmaceutical
... to manufacturing processes, drug properties, and product quality attributes such as stability, solubility, and dissolution. These include formulation changes, capsule changes, storage, handling, processing conditions, product packaging, and other considerations. INTRODUCTION Two-piece hard capsules ...
... to manufacturing processes, drug properties, and product quality attributes such as stability, solubility, and dissolution. These include formulation changes, capsule changes, storage, handling, processing conditions, product packaging, and other considerations. INTRODUCTION Two-piece hard capsules ...
Medicines Information Bulletin - Oxford Health NHS Foundation
... Depakote (semi-sodium valproate) should only be prescribed for patients who are currently stabilised on this drug. However, consideration should be given to switching these patients over to sodium valproate where possible. Please note that Depakote is traffic lighted red in Buckinghamshire and will ...
... Depakote (semi-sodium valproate) should only be prescribed for patients who are currently stabilised on this drug. However, consideration should be given to switching these patients over to sodium valproate where possible. Please note that Depakote is traffic lighted red in Buckinghamshire and will ...
APRI 7149$
... In the United States, ephedrine is available over–the– counter (OTC) for use as a bronchodilator, decongestant, and in In recent years, dietary supplements allergy products. have been marketed in the United States which contain various quantities of ephedra alkaloids. Some of these products are posi ...
... In the United States, ephedrine is available over–the– counter (OTC) for use as a bronchodilator, decongestant, and in In recent years, dietary supplements allergy products. have been marketed in the United States which contain various quantities of ephedra alkaloids. Some of these products are posi ...
PRODUCT INFORMATION MS Contin® modified release tablets 5
... The inactive ingredients in MS Contin modified release tablets (also referred as MS Contin tablets) are: lactose anhydrous (except 100 mg and 200 mg), hydroxyethylcellulose, cetostearyl alcohol, magnesium stearate and purified talc. MS Contin tablets are coated with hypromellose (except 10 mg), macr ...
... The inactive ingredients in MS Contin modified release tablets (also referred as MS Contin tablets) are: lactose anhydrous (except 100 mg and 200 mg), hydroxyethylcellulose, cetostearyl alcohol, magnesium stearate and purified talc. MS Contin tablets are coated with hypromellose (except 10 mg), macr ...
SEMINAR ON BUCCAL DRUG DELIVERY SYSTUM
... sugar Such as sorbitol,combined such that buccal tablets dissolves in about one minute. It includes. -buccally absorbable active ingredients -a lubricant (mg stearate,sds) -soluble,directly compressible excipients(spray dried sorbitol) - such rapid delivery is useful for delivering a bolus dose to a ...
... sugar Such as sorbitol,combined such that buccal tablets dissolves in about one minute. It includes. -buccally absorbable active ingredients -a lubricant (mg stearate,sds) -soluble,directly compressible excipients(spray dried sorbitol) - such rapid delivery is useful for delivering a bolus dose to a ...
1. NAME OF THE MEDICINAL PRODUCT Dompicare 20 mg, film
... The relief of the symptoms of nausea and vomiting, epigastric sense of fullness, upper abdominal discomfort and regurgitation of gastric contents. Adolescents (over 12 years and weighing 35 kg or more) The relief of the symptoms of nausea and vomiting. 4.2. Posology and method of administration It i ...
... The relief of the symptoms of nausea and vomiting, epigastric sense of fullness, upper abdominal discomfort and regurgitation of gastric contents. Adolescents (over 12 years and weighing 35 kg or more) The relief of the symptoms of nausea and vomiting. 4.2. Posology and method of administration It i ...
Evaluating drugs used to treat fibromyalgia
... expensive for manufacturing companies, so older drugs that are already approved for other uses may not be taken through this process. In practice, often more than one medication is used to treat fibromyalgia, but there have been very few studies that evaluated the effectiveness of combination treatm ...
... expensive for manufacturing companies, so older drugs that are already approved for other uses may not be taken through this process. In practice, often more than one medication is used to treat fibromyalgia, but there have been very few studies that evaluated the effectiveness of combination treatm ...
3) Antihypertensive Drugs (Cont`d)
... 3) Antihypertensive Drugs (Cont’d) – Side effects: Hypotension, dizziness, weakness, ...
... 3) Antihypertensive Drugs (Cont’d) – Side effects: Hypotension, dizziness, weakness, ...
The problem with current OTC pain relievers - Aspir-Tek
... The scientists at PharmStar have been developing for a period of over 20 years to effectively, rapidly, and completely convert common aspirin, the “GOLD STANDARD” of pain relievers, into a much more effective and safer form. What has been achieved is the most significant breakthrough in the pain rel ...
... The scientists at PharmStar have been developing for a period of over 20 years to effectively, rapidly, and completely convert common aspirin, the “GOLD STANDARD” of pain relievers, into a much more effective and safer form. What has been achieved is the most significant breakthrough in the pain rel ...
Paracetamol use (and/or misuse)
... Enugu, South-East Nigeria. To the best of our knowledge there is a dearth of published work on paracetamol use in the area and in Nigeria in general. It is hoped that this study may shed more light on the subject with a view to encouraging rational use of this common pharmaceutical agent in children ...
... Enugu, South-East Nigeria. To the best of our knowledge there is a dearth of published work on paracetamol use in the area and in Nigeria in general. It is hoped that this study may shed more light on the subject with a view to encouraging rational use of this common pharmaceutical agent in children ...
Penicillin VK - The Main Line Center for the Family
... The potassium salt of penicillin V has the distinct advantage over penicillin G in resistance to inactivation by gastric acid. It may be given with meals; however, blood levels are slightly higher when the drug is given on an empty stomach. Average blood levels are two to five times higher than the ...
... The potassium salt of penicillin V has the distinct advantage over penicillin G in resistance to inactivation by gastric acid. It may be given with meals; however, blood levels are slightly higher when the drug is given on an empty stomach. Average blood levels are two to five times higher than the ...
Tablet (pharmacy)
A tablet is a pharmaceutical dosage form. Tablets may be defined as the solid unit dosage form of medicament or medicaments with or without suitable diluents and prepared either by molding or by compression. It comprises a mixture of active substances and excipients, usually in powder form, pressed or compacted from a powder into a solid dose. The excipients can include diluents, binders or granulating agents, glidants (flow aids) and lubricants to ensure efficient tabletting; disintegrants to promote tablet break-up in the digestive tract; sweeteners or flavours to enhance taste; and pigments to make the tablets visually attractive. A polymer coating is often applied to make the tablet smoother and easier to swallow, to control the release rate of the active ingredient, to make it more resistant to the environment (extending its shelf life), or to enhance the tablet's appearance.The compressed tablet is the most popular dosage form in use today. About two-thirds of all prescriptions are dispensed as solid dosage forms, and half of these are compressed tablets. A tablet can be formulated to deliver an accurate dosage to a specific site; it is usually taken orally, but can be administered sublingually, buccally, rectally or intravaginally. The tablet is just one of the many forms that an oral drug can take such as syrups, elixirs, suspensions, and emulsions. Medicinal tablets were originally made in the shape of a disk of whatever color their components determined, but are now made in many shapes and colors to help distinguish different medicines. Tablets are often stamped with symbols, letters, and numbers, which enable them to be identified. Sizes of tablets to be swallowed range from a few millimeters to about a centimeter.